Stay updated on IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.

Latest updates to the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history, indicating an updated version of the record, and the previous revision v3.6.5 was removed from the visible list.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s revision label in the footer was updated from v3.6.4 to v3.6.5, signaling a minor platform update rather than a change to the study data list. This update affects how the page presents its version, not the content of the record history.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing v3.6.3. This appears to be a metadata update rather than a user-facing content change.SummaryDifference0.1%

- Check63 days agoChange DetectedThe record history now shows a new revision label v3.6.3, replacing the previous v3.6.2. This indicates a backend/UI update to how the history is presented for this study page.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page’s revision label was updated to v3.6.2, replacing the previous v3.6.0, indicating a platform version update reflected in the history view rather than a modification to the study data.SummaryDifference0.1%

- Check84 days agoChange DetectedRecruitment status updated to not looking for participants. The record shows a new revision (v3.6.0) and the prior revision (v3.5.5) was removed.SummaryDifference0.2%

Stay in the know with updates to IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.